What is Ibandronate?

Category: Prescription Drugs

Most popular types: Boniva Boniva infusion

false

Ibandronate sodium is a potent bisphosphonate drug used in the prevention and treatment of osteoporosis. It may also be used to treat hypercalcemia (elevated blood calcium levels).

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Osteoporosis 43 11
Osteopenia 14 6
General health 2 0
Treat side effects of another treatment 2 2
Doctor recommendation 1 0
Rheumatoid arthritis 1 0

Show all 8 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 2
Moderate 1
Mild 7
None 11

Commonly reported side effects and conditions associated with Ibandronate

Side effect Patients Percentage
Acid reflux 3
Heartburn 2
Achiness 1
Dizziness 1
Indigestion 1
Joint stiffness 1

Show all 9 reported side effects

Why patients stopped taking Ibandronate

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 8
Other 8
Expense 5
Did not seem to work 3
Personal research 3
Side effects too severe 3
Change in health plan coverage 2
Course of treatment ended 1
See all 26 patients who've stopped taking Ibandronate

Duration

Stopped taking Ibandronate

Duration Patients Percentage
Less than 1 month 4
1 - 6 months 2
6 months - 1 year 2
1 - 2 years 5
2 - 5 years 5
5 - 10 years 6
Adherence
Adherence Evaluations Percentage
Always 12
Usually 6
Sometimes 3
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 1
Somewhat hard to take 5
A little hard to take 11
Not at all hard to take 4
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 1
$50-99 6
$25-49 5
< $25 4
Not specified 5

What people switch to and from

Patients started taking Ibandronate after stopping:

Treatment Patients Percentage
Raloxifene (Evista) 1
Risedronate (Actonel) 1

Patients stopped taking Ibandronate and switched to:

Treatment Patients Percentage
Denosumab (Prolia) 1
Tocilizumab (Actemra) 1
Last updated:

1 patient evaluation for Ibandronate

Feb 2, 2012 (Started Mar 13, 2008)

  • Effectiveness
    Can't tell (for Other)
  • Side effects
    None
  • Adherence
    Sometimes
  • Burden
    A little hard to take
Dosage:

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Ibandronate